No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:10290200-10351400 |
Strong transcription |
Dnd41 |
blood
|
2 |
chr2:10302400-10337600 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
3 |
chr2:10304400-10339800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
4 |
chr2:10311800-10337000 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
5 |
chr2:10313000-10344400 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
6 |
chr2:10314000-10340400 |
Weak transcription |
HepG2 |
liver
|
7 |
chr2:10320600-10337200 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
8 |
chr2:10321800-10338000 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
9 |
chr2:10325600-10342800 |
Weak transcription |
Fetal Brain Female |
brain
|
10 |
chr2:10326600-10339400 |
Strong transcription |
Thymus |
Thymus
|
11 |
chr2:10329000-10337200 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
12 |
chr2:10332000-10337400 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
13 |
chr2:10333000-10347000 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
14 |
chr2:10334200-10337000 |
Weak transcription |
Primary monocytes fromperipheralblood |
blood
|
15 |
chr2:10335200-10338000 |
Strong transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
16 |
chr2:10335200-10348600 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
17 |
chr2:10335400-10337200 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
18 |
chr2:10335800-10337200 |
Enhancers |
Spleen |
Spleen
|
19 |
chr2:10335800-10337400 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
20 |
chr2:10336000-10337200 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
21 |
chr2:10336200-10337200 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
22 |
chr2:10336200-10337200 |
Enhancers |
Fetal Intestine Large |
intestine
|
23 |
chr2:10336200-10337200 |
Enhancers |
Fetal Muscle Leg |
muscle
|
24 |
chr2:10336200-10337400 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
25 |
chr2:10336200-10337400 |
Enhancers |
Brain Substantia Nigra |
brain
|
26 |
chr2:10336200-10337400 |
Enhancers |
Fetal Lung |
lung
|
27 |
chr2:10336400-10337000 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
28 |
chr2:10336400-10337000 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
29 |
chr2:10336400-10337000 |
Enhancers |
NH-A |
brain
|
30 |
chr2:10336400-10337200 |
Enhancers |
Brain Inferior Temporal Lobe |
brain
|
31 |
chr2:10336400-10337200 |
Enhancers |
HSMMtube |
muscle
|
32 |
chr2:10336400-10338000 |
Weak transcription |
Fetal Intestine Small |
intestine
|
33 |
chr2:10336400-10338600 |
ZNF genes & repeats |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
34 |
chr2:10336400-10338800 |
ZNF genes & repeats |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
35 |
chr2:10336600-10337000 |
Enhancers |
Brain Germinal Matrix |
brain
|
36 |
chr2:10336600-10337000 |
Enhancers |
Sigmoid Colon |
Sigmoid Colon
|
37 |
chr2:10336600-10337200 |
Bivalent Enhancer |
Placenta |
Placenta
|
38 |
chr2:10336600-10337200 |
Enhancers |
Gastric |
stomach
|
39 |
chr2:10336600-10337200 |
Enhancers |
Stomach Mucosa |
stomach
|
40 |
chr2:10336600-10337400 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
41 |
chr2:10336600-10338200 |
Weak transcription |
Primary neutrophils fromperipheralblood |
blood
|
42 |
chr2:10336800-10337000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
43 |
chr2:10336800-10337200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
44 |
chr2:10336800-10337600 |
Enhancers |
Fetal Brain Male |
brain
|
45 |
chr2:10336800-10338200 |
Weak transcription |
Fetal Thymus |
thymus
|
46 |
chr2:10336800-10344600 |
Weak transcription |
Brain Hippocampus Middle |
brain
|